HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Combe, Inc.

Summer’s Eve Removes Three Colorants From Feminine Washes, A ‘Huge Win’ For Women’s Voices

Women’s Voices for the Earth says Prestige Brands has “quietly reformulated” Summer’s Eve products to eliminate three colorants that should not be in feminine washes, based on FDA regulations and the realities of consumer practices and women’s anatomy. Now the NGO is considering next steps.

Beauty Cosmetics

Senator Seeks Trove Of Talc/Asbestos Docs From J&J; FDA On Status Of Lead Acetate Rule; Beauty News In Brief

The Senate Health Committee’s ranking member is “troubled” by a recent Reuters article, requesting numerous documents from J&J related to talc-asbestos testing and the firm’s communications with FDA and consumers on the subject. More beauty news in brief.

Beauty Regulation

FDA May Put Hold On Lead Acetate Hair-Dye Rule; Manufacturer Combe Demands Hearing

Grecian Formula marketer Combe likens the process and calculations that informed FDA’s final rule against lead acetate to “a child’s game of telephone.” Environmental Defense Fund warns that if FDA grants Combe’s request – which the NGO suspects is unavoidable – it intends to cross-examine the company’s witnesses about consumer complaints and their handling in the firm’s past.

FDA Regulation

In Time For Halloween, FDA Rule Conjures Up Specter Of Renewed Cosmetic Lead Debate

FDA’s final rule is specific to lead acetate’s use in hair-coloring products, but the agency’s recognition of current consensus – “that there is no safe exposure level for lead” – could spook the wider cosmetics industry, particularly given that some of the same NGO petitioners that drove the rulemaking are clamoring for an all-out ban on trace lead in lipsticks and externally applied cosmetics.

Regulation FDA
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register